PRELIMINARY EXPERIENCE WITH A COMBINED-MODALITY APPROACH TO THE MANAGEMENT OF ESOPHAGEAL CANCER

被引：14

作者：

DENHAM, JW

GILL, PG

JAMIESON, GG

HETZEL, D

DEVITT, P

FITCH, R

BRITTENJONES, R

GIBSON, GE

ABBOTT, RL

HECKER, R

WILLIAMS, RS

OLWENY, CL

机构：

[1] ROYAL ADELAIDE HOSP, DEPT RADIAT ONCOL, ADELAIDE, SA 5000, AUSTRALIA

[2] ROYAL ADELAIDE HOSP, DEPT GASTROENTEROL, ADELAIDE, SA 5000, AUSTRALIA

[3] ROYAL ADELAIDE HOSP, OESOPHAGAGASTR SURG UNIT, ADELAIDE, SA 5000, AUSTRALIA

[4] ROYAL ADELAIDE HOSP, DEPT MED ONCOL, ADELAIDE, SA 5000, AUSTRALIA

[5] UNIV ADELAIDE, ROYAL ADELAIDE HOSP, DEPT SURG, ADELAIDE, SA 5001, AUSTRALIA

来源：

关键词：

D O I：

10.5694/j.1326-5377.1988.tb104471.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9 / 13

页数：5

共 21 条

[1] PHARMACOLOGIC REQUIREMENTS FOR OBTAINING SENSITIZATION OF HUMAN-TUMOR CELLS-INVITRO TO COMBINED 5-FLUOROURACIL OR FTORAFUR AND X-RAYS
BYFIELD, JE
CALABROJONES, P
KLISAK, I
KULHANIAN, F
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11): : 1923 - 1933
[2] BYFIELD JE, 1983, CANCER TREAT REP, V67, P709
[3] BYFIELD JE, 1980, CANCER-AM CANCER SOC, V45, P703, DOI 10.1002/1097-0142(19800215)45:4<703::AID-CNCR2820450415>3.0.CO
[4] 2-Q
[5] CLIFTON P, 1983, 10 YEARS EXPERIENCE
[6] COONLEY CJ, 1984, CANCER, V54, P2351, DOI 10.1002/1097-0142(19841201)54:11<2351::AID-CNCR2820541107>3.0.CO
[7] 2-H
[8] DEBESI P, 1986, P AN M AM SOC CLIN, V5, P148
[9] KELSEN D, 1984, SEMIN ONCOL, V11, P159
[10] LAUNOIS B, 1981, SURG GYNECOL OBSTET, V153, P690